Lead Sponsor

University Hospital, Clermont-Ferrand

Collaborators

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

•" Score For Allergic Rhinitis " ≥ 8
•Age ≥ 18
•Able to refrain from using any treatment for allergic rhinitis or any other treatment that could interfere with the purpose of the study,
•Effective contraception for women of reproductive age,
•Cooperation and understanding sufficient to comply with the requirements of the study,
•Acceptance to give written consent and inscription to VRB french platform for the duration of the study,
•Affiliation to the French Social Security system,

•Known hypersensitivity to any of the components of the evaluated products,
•Use of any treatment to treat allergic rhinitis,
•pregnant or breastfeeding women,
•participating in another clinical trial, or being in the exclusion period, or having received a total amount of benefits exceeding EUR 6000 over the 12 months preceding the start of the trial,
•benefiting from a measure of legal protection (guardianship, deprivation of liberty, safeguard of justice),
•having a medical and / or surgical history judged by the investigator or his representative to be incompatible with the test

Related studies

NCT06547372 · Atopic Dermatitis, Atopic, and more

NCT07419230 · Allergic Rhinitis

NCT07453615 · Anxiety, Fear Anxiety, and more

NCT06732414 · Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a

NCT05494346 · Acute Rhinitis, Nasal Obstruction, and more

Evaluation of Treatments for Allergic Rhinitis (Rhinal 2)